Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Daikos

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective surveyM Psichogiou, P T Tassios, A Avlamis, et al.
Annals of Internal Medicine|August 1, 1992
An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infectionM A Fischl, R B Uttamchandani, G L Daikos, et al.
Annals of Internal Medicine|August 1, 1992
Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilliM A Fischl, G L Daikos, R B Uttamchandani, et al.
International Journal of Antimicrobial Agents|June 2, 2007
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiologyG Poulakou, I Katsarolis, I Matthaiopoulou, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2017
Management of KPC-producing Klebsiella pneumoniae infectionsM Bassetti, D R Giacobbe, H Giamarellou, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2020
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry studyI Karaiskos, G L Daikos, A Gkoufa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2018
Combining VITEK<sup>®</sup> 2 with colistin agar dilution screening assist timely reporting of colistin susceptibilityJ Lellouche, D Schwartz, N Elmalech, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 28, 2020
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteriaA N Kristoffersson, V Rognås, M J E Brill, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 10, 2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissionsD Paraskevis, E Kostaki, G Magiorkinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective surveyM Psichogiou, P T Tassios, A Avlamis, et al.
Annals of Internal Medicine|August 1, 1992
An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infectionM A Fischl, R B Uttamchandani, G L Daikos, et al.
Annals of Internal Medicine|August 1, 1992
Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilliM A Fischl, G L Daikos, R B Uttamchandani, et al.
International Journal of Antimicrobial Agents|June 2, 2007
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiologyG Poulakou, I Katsarolis, I Matthaiopoulou, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2017
Management of KPC-producing Klebsiella pneumoniae infectionsM Bassetti, D R Giacobbe, H Giamarellou, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2020
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry studyI Karaiskos, G L Daikos, A Gkoufa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2018
Combining VITEK<sup>®</sup> 2 with colistin agar dilution screening assist timely reporting of colistin susceptibilityJ Lellouche, D Schwartz, N Elmalech, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 28, 2020
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteriaA N Kristoffersson, V Rognås, M J E Brill, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 10, 2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissionsD Paraskevis, E Kostaki, G Magiorkinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 6